US Oncology VP of Finance Salaries in Wilmington, DE | Comparably
US Oncology operates a network of integrated community-based oncology practices that provides cancer care services in the United States. read more
EMPLOYEE
PARTICIPANTS
80
TOTAL
RATINGS
550

US Oncology VP of Finance Salaries in Wilmington, DE

The average US Oncology VP of Finance in Wilmington, DE earns an estimated $155,643 annually. US Oncology's VP of Finance compensation is $50,887 less than the US average for a VP of Finance.

In Wilmington, DE, The Finance Department at US Oncology earns $16,645 more on average than the Admin Department.

Last updated 9 months ago.

$50k
$90k
$145k
$200k
$309k
$430k
$518k
$155,643
Average Compensation
$155,643
avg. base

VP of Finance Salaries at US Oncology

In Wilmington, DE, VPs of Finance earn $34,416 more than Accounting Managers.

Accounting Manager
$121k*
Business Analyst
$96k*
Senior Accountant
$92k*
Accountant
$71k*
Financial Analyst
$68k*
* estimated salary

Compensation at US Oncology by Department

In Wilmington, DE, The Finance Department averages $16,645 more than the Admin Department, and $10,806 less than the IT Department

IT
$95,561 Avg. total comp.
+$11k
Finance
$84,755 Avg. total comp.
Admin
$68,110 Avg. total comp.
-$17k

VP of Finance Compensation by Gender (All Companies)

The average female VP of Finance at companies similar size to US Oncology reported making $188,034, while the average male VP of Finance at similar sized companies reported making $216,094.

VP of Finance Compensation by Ethnicity (All Companies)

The average Caucasian VP of Finance at companies similar size to US Oncology reported making $207,596, while the average Hispanic or Latino VP of Finance at similar sized companies reported making $170,500.

How VPs of Finance at US Oncology Rate Their Compensation

The majority of VPs of Finance at US Oncology believe they're compensated fairly. 50% of VPs of Finance at US Oncology say they receive annual bonuses, and the majority (60%) are satisfied with their benefits. See more compensation ratings at US Oncology

×
Rate your company